Stewart J D, Krebs J F, Siuzdak G, Berdis A J, Smithrud D B, Benkovic S J
Department of Chemistry, Pennsylvania State University, University Park 16802.
Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7404-9. doi: 10.1073/pnas.91.16.7404.
Antibody 43C9 accelerates the hydrolysis of a p-nitroanilide by a factor of 2.5 x 10(5) over the background rate in addition to catalyzing the hydrolysis of a series of aromatic esters. Since this represents one of the largest rate accelerations achieved with an antibody, we have undertaken a series of studies aimed at uncovering the catalytic mechanism of 43C9. The immunogen, a phosphonamidate, was designed to mimic the geometric and electronic characteristics of the tetrahedral intermediate that forms upon nucleophilic attack by hydroxide on the amide substrate. Further studies, however, revealed that the catalytic mechanism is more complex and involves the fortuitous formation of a covalent acyl-antibody intermediate as a consequence of complementary side chain residues at the antibody-binding site. Several lines of evidence indicate that the catalytic mechanism involves two key residues: His-L91, which acts as a nucleophile to form the acyl-antibody intermediate, and Arg-L96, which stabilizes the anionic tetrahedral moieties. Support for this mechanism derives from the results of site-directed mutagenesis experiments and solvent deuterium isotope effects as well as direct detection of the acyl-antibody by electrospray mass spectrometry. Despite its partial recapitulation of the course of action of enzymic counterparts, the reactivity of 43C9, like other antibodies, is apparently limited by its affinity for the inducing immunogen. To go beyond this level, one must introduce additional catalytic functionality, particularly general acid-base catalysis, through either improvements in transition-state analog design or site-specific mutagenesis.
抗体43C9除了催化一系列芳香酯的水解外,还能使对硝基苯胺的水解速率比背景速率加快2.5×10⁵倍。由于这是抗体实现的最大速率加速之一,我们开展了一系列研究,旨在揭示43C9的催化机制。免疫原是一种氨基磷酸酯,其设计目的是模拟氢氧根对酰胺底物进行亲核攻击时形成的四面体中间体的几何和电子特征。然而,进一步的研究表明,催化机制更为复杂,涉及抗体结合位点处互补侧链残基偶然形成的共价酰基抗体中间体。几条证据表明,催化机制涉及两个关键残基:His-L91,它作为亲核试剂形成酰基抗体中间体;Arg-L96,它稳定阴离子四面体部分。对这一机制的支持来自定点诱变实验结果、溶剂氘同位素效应以及通过电喷雾质谱直接检测酰基抗体。尽管43C9部分重现了酶对应物的作用过程,但其反应性与其他抗体一样,显然受到其对诱导免疫原亲和力的限制。要超越这一水平,必须通过改进过渡态类似物设计或定点诱变引入额外的催化功能,特别是酸碱催化功能。